Barron's

This weekend in Barron's online: the top 50 annuities, Intel finally goes mobile, what tech companies should do with all that cash, and the prospects for Snap-on. Cover Story "The Top 50 Annuities" by Karen Hube. A year ago, guaranteed payouts and benefits on all kinds of annuities were far more...

This weekend in Barron's online: Hedge-fund manager Ray Dalio's thoughts on the troubles in Europe, the effect of comments made by David Einhorn, and the consequences of the Facebook IPO flop. Cover Story "Ray Dalio's World" by Sandra Ward. Ray Dalio, fabled hedge-fund manager, is the head of...

This weekend in Barron's online: the pros and cons of memory-foam mattresses and the prospects for Facebook's IPO and for aircraft maker Embraer and semiconductor testing equipment maker ChipMOS. Cover Story "Sex or Sleep?" by Miriam Gottfried. Sales of memory-foam mattresses have surged as more...

This weekend in Barron's online: the annual ranking of the top 500 companies (as well as finding bargain stocks from the list) and the prospects for airline United Continental, insurer Unum Group and the recently spun-off Phillips 66. Cover Story "Bravo to the Best!" by Jacqueline Doherty. It is...

This weekend in Barron's online: The Dow Jones Industrial Average is overdue for a makeover, and the prospects for eBay, Thermo Fisher Scientific and Oracle. Cover Story "Shake Up the Dow!" by Andrew Bary. Barron's cover story this week suggests that the Dow Jones Industrial Average risks...

This weekend in Barron's online: The latest Big Money poll of America's portfolio managers, a cool off in the prices of U.S. farmland, and the prospects for Francesca's Holdings, Devon Energy and LSI. Cover Story "Reason to Cheer" by Jack Willoughby. In Barron's latest Big Money poll, America's...

This weekend in Barron's online: Student-loan debt drags on the economy, a look at Kohl's and Seagate Technology, and what America's top 100 financial advisors are recommending. Cover Story "What a Drag" by Jonathan R. Laing. Student-loan debt is compounding at an alarming rate. Last month the...

This weekend in Barron's online: this quarter's mutual fund feature is on Legg Mason, the chances of Q3 dwindle, data suggest the 1% are paying their fair share of taxes, Icahn is beating the S&P 500 again, and could the U.S. become the world's largest exporter of liquid natural gas? Cover...

Alexion Pharmaceuticals (NASDAQ: ALXN) specializes in extremely rare diseases. Its only marketed drug, Soliris, currently targets paroxysmal Nocturnal Hemoglobinuria (PNH) a condition afflicting less than 10 thousand people worldwide. At an estimated annual cost of $400 thousand per patient,...

Barron's Jim McTague recently wrote an article highlighting GOP presidential contender Ron Paul's investing strategy. Not surprisingly, the Texas Congressman has whipped the markets with his stock picks, which consist primarily of buying precious metals miners. The author of the Barron's piece,...